STAT - Reporting from the frontiers of health and medicine

Politics

Politics

The Readout LOUD

First Opinion Even me-too drugs matter when it comes to new medicines
A STAT Investigation ‘Health equity tourists’: How white scholars are colonizing research on health disparities
Exclusive Biogen’s Aduhelm sales slower than disclosed, forcing company to consider cost-cutting measures
Health Tech The ‘Great Resignation’ could be health tech’s next big sales pitch
First Opinion Space-bound billionaires can help make the world a healthier place through research

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

WHO adds Regeneron drug to recommended Covid-19 treatments, but criticizes its pricing
Defense Department watchdog criticizes oversight of military’s pharmaceutical supply chain
‘It’s never one-size-fits all’: Health tech leaders look to design to make care more equitable

Health

Health

Special Report

A STAT Investigation

Health

Heavyweights

First Opinion How a ‘fatally, tragically flawed’ paradigm has derailed the science of obesity
Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Politics Biden’s chaotic messaging on Covid-19 boosters is pitting the White House against the government’s scientific advisers
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
A STAT Investigation ‘Health equity tourists’: How white scholars are colonizing research on health disparities
Health How the risk of side effects could change with Covid-19 vaccine boosters
The Readout LOUD Scott Gottlieb on Covid, a better CDC, and how he does it all
Health How the Covid pandemic ends: Scientists look to the past to see the future